Open House Biologics Discount Agreements 2025-25 - Aflibercept (ATC: S01LA05; Potency: 40 mg/ml)
By: TECHNICIANS' HEALTH INSURANCE๐ GermanyOpen
Key Information
| Reference | GB-386710-2026 |
|---|
| Deadline | Nov 30, 2026 12:00 AM |
|---|
| Competition Type | NCB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Germany |
|---|
| Address | City : Hamburg
Postal code : 22305
Telephone : +49 4069094-040
Country : Germany |
|---|
| Published | Jun 5, 2026 |
|---|
Description
<br/>The TK pursues the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 SGB V for the active ingredient aflibercept (ATC: ...
Full details are available after unlocking this tender.